2-166039215-T-C

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_001165963.4(SCN1A):​c.2589+208A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.738 in 152,120 control chromosomes in the GnomAD database, including 41,785 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.74 ( 41785 hom., cov: 33)

Consequence

SCN1A
NM_001165963.4 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -1.63

Publications

2 publications found
Variant links:
Genes affected
SCN1A (HGNC:10585): (sodium voltage-gated channel alpha subunit 1) Voltage-dependent sodium channels are heteromeric complexes that regulate sodium exchange between intracellular and extracellular spaces and are essential for the generation and propagation of action potentials in muscle cells and neurons. Each sodium channel is composed of a large pore-forming, glycosylated alpha subunit and two smaller beta subunits. This gene encodes a sodium channel alpha subunit, which has four homologous domains, each of which contains six transmembrane regions. Allelic variants of this gene are associated with generalized epilepsy with febrile seizures and epileptic encephalopathy. Alternative splicing results in multiple transcript variants. The RefSeq Project has decided to create four representative RefSeq records. Three of the transcript variants are supported by experimental evidence and the fourth contains alternate 5' untranslated exons, the exact combination of which have not been experimentally confirmed for the full-length transcript. [provided by RefSeq, Oct 2015]
SCN1A-AS1 (HGNC:54069): (SCN1A and SCN9A antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 2-166039215-T-C is Benign according to our data. Variant chr2-166039215-T-C is described in ClinVar as Benign. ClinVar VariationId is 669303.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.869 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001165963.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SCN1A
NM_001165963.4
MANE Select
c.2589+208A>G
intron
N/ANP_001159435.1P35498-1
SCN1A
NM_001202435.3
c.2589+208A>G
intron
N/ANP_001189364.1P35498-1
SCN1A
NM_001353948.2
c.2589+208A>G
intron
N/ANP_001340877.1P35498-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SCN1A
ENST00000674923.1
MANE Select
c.2589+208A>G
intron
N/AENSP00000501589.1P35498-1
SCN1A
ENST00000303395.9
TSL:5
c.2589+208A>G
intron
N/AENSP00000303540.4P35498-1
SCN1A
ENST00000375405.7
TSL:5
c.2556+208A>G
intron
N/AENSP00000364554.3P35498-2

Frequencies

GnomAD3 genomes
AF:
0.738
AC:
112103
AN:
152002
Hom.:
41740
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.824
Gnomad AMI
AF:
0.645
Gnomad AMR
AF:
0.742
Gnomad ASJ
AF:
0.603
Gnomad EAS
AF:
0.890
Gnomad SAS
AF:
0.709
Gnomad FIN
AF:
0.756
Gnomad MID
AF:
0.525
Gnomad NFE
AF:
0.683
Gnomad OTH
AF:
0.680
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.738
AC:
112209
AN:
152120
Hom.:
41785
Cov.:
33
AF XY:
0.741
AC XY:
55098
AN XY:
74354
show subpopulations
African (AFR)
AF:
0.823
AC:
34162
AN:
41488
American (AMR)
AF:
0.742
AC:
11344
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.603
AC:
2090
AN:
3468
East Asian (EAS)
AF:
0.890
AC:
4604
AN:
5172
South Asian (SAS)
AF:
0.709
AC:
3426
AN:
4830
European-Finnish (FIN)
AF:
0.756
AC:
8001
AN:
10586
Middle Eastern (MID)
AF:
0.520
AC:
153
AN:
294
European-Non Finnish (NFE)
AF:
0.683
AC:
46399
AN:
67978
Other (OTH)
AF:
0.683
AC:
1442
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1519
3039
4558
6078
7597
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
848
1696
2544
3392
4240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.634
Hom.:
2008
Bravo
AF:
0.741
Asia WGS
AF:
0.789
AC:
2743
AN:
3476

ClinVar

ClinVar submissions as Germline
Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
0.31
DANN
Benign
0.34
PhyloP100
-1.6
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1019724; hg19: chr2-166895725; API